REGN
Regeneron Pharmaceuticals Inc
788.00$
-1.0%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 5.9% | 8.4% | 9.3% | 9.4% | 9.5% | 8.9% | 10.0% | 7.8% | 8.8% | 8.3% | 16.3% | 12.5% | 16.0% | 14.8% | 15.0% | 17.1% | 14.5% | 17.1% | 14.8% | 14.9% | 15.2% | 21.3% | 16.2% | 13.0% | 14.0% | 14.8% | 17.6% | 16.1% | 16.1% | 18.3% | 13.8% | 13.5% | 13.2% | 14.9% | 15.3% | 14.4% | 13.9% | 15.1% | 18.6% | 13.4% | 15.1% | |
| 94.1% | 91.6% | 90.7% | 90.6% | 90.5% | 91.1% | 90.0% | 92.2% | 91.2% | 91.7% | 83.7% | 87.5% | 84.0% | 85.2% | 85.0% | 82.9% | 85.5% | 82.9% | 85.2% | 85.1% | 84.8% | 78.7% | 83.8% | 87.0% | 86.0% | 85.2% | 82.4% | 83.9% | 83.9% | 81.7% | 86.2% | 86.5% | 86.8% | 85.1% | 84.7% | 85.6% | 86.1% | 84.9% | 81.4% | 86.6% | 84.9% | |
| 42.2% | 36.7% | 35.6% | 32.3% | 32.8% | 31.2% | 30.6% | 30.8% | 31.4% | 29.0% | 31.7% | 52.8% | 27.1% | 36.7% | 28.9% | 34.0% | 27.3% | 28.2% | 26.7% | 12.5% | 17.2% | 14.4% | 26.0% | 25.2% | 27.9% | 27.6% | 31.7% | 31.1% | 28.8% | 30.6% | 39.9% | 34.5% | 35.7% | 37.6% | 44.2% | 39.0% | 41.5% | 41.9% | 45.6% | 38.0% | 41.6% | |
| 22.1% | 26.6% | 22.5% | 20.9% | 20.4% | 25.9% | 21.9% | 22.7% | 22.2% | 25.5% | 29.9% | 26.4% | 24.1% | 31.5% | 20.1% | 17.8% | 14.3% | 15.2% | 16.0% | 8.1% | 12.9% | 11.3% | 15.2% | 16.7% | 18.0% | 19.3% | 19.0% | 20.6% | 19.0% | 21.5% | 21.9% | 21.4% | 19.2% | 20.9% | 20.9% | 17.3% | 17.5% | 20.0% | 18.0% | 15.4% | 17.7% | |
| 64.4% | 63.3% | 58.1% | 53.2% | 53.2% | 57.1% | 52.5% | 53.5% | 53.5% | 54.5% | 48.8% | 67.5% | 41.7% | 48.9% | 46.8% | 49.2% | 39.6% | 34.7% | 41.2% | 20.0% | 31.3% | 25.3% | 40.4% | 41.3% | 44.3% | 46.6% | 50.7% | 51.7% | 47.9% | 51.1% | 62.3% | 56.3% | 55.1% | 58.9% | 65.1% | 56.2% | 58.8% | 62.3% | 63.6% | 53.5% | 59.3% | |
| 29.7% | 28.3% | 32.6% | 37.4% | 37.3% | 34.0% | 37.5% | 38.7% | 37.7% | 37.2% | 35.0% | 20.0% | 42.4% | 36.3% | 38.3% | 33.6% | 45.9% | 48.2% | 44.0% | 65.1% | 53.5% | 53.3% | 43.4% | 45.7% | 41.7% | 38.5% | 31.7% | 32.2% | 36.0% | 30.6% | 23.9% | 30.2% | 31.7% | 26.1% | 19.5% | 29.4% | 27.3% | 22.7% | 17.8% | 33.1% | 25.6% | |
| 0.0% | 0.3% | 0.6% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.4% | 0.6% | 0.5% | 0.4% | 0.4% | 0.3% | 0.5% | 1.1% | 0.6% | 0.6% | 0.3% | 0.4% | 0.3% | 0.5% | 0.5% | 0.5% | 0.5% | 0.6% | 0.6% | 0.5% | 0.5% | 0.5% | 0.4% | 0.4% | 0.3% | 0.3% | 0.1% | 0.5% | 0.3% | 0.4% | 0.3% | 0.4% | |
| 30.0% | 27.8% | 32.8% | 35.8% | 37.7% | 35.1% | 38.7% | 40.8% | 38.2% | 35.1% | 39.8% | 14.2% | 44.1% | 47.7% | 36.6% | 47.1% | 43.5% | 50.5% | 49.6% | 73.0% | 52.6% | 50.6% | 35.8% | 33.7% | 51.4% | 38.8% | 27.1% | 34.3% | 33.0% | 33.4% | 22.3% | 45.9% | 40.1% | 25.3% | 29.9% | 41.3% | 47.0% | 26.9% | 23.1% | 35.6% | 33.3% | |
| 8.3% | 7.2% | 13.9% | 9.4% | 11.8% | 24.1% | 7.1% | 6.5% | 2.5% | -7.5% | 6.2% | 2.0% | 5.7% | 5.2% | 2.4% | 1.1% | 6.8% | 3.1% | 5.4% | 12.7% | 5.3% | 5.5% | 3.0% | 3.9% | 6.6% | 3.7% | 1.3% | 3.6% | 3.1% | -0.3% | -0.7% | 5.5% | 4.1% | 1.1% | 3.2% | 3.5% | 8.1% | 5.1% | 2.9% | 5.4% | 5.4% | |
| 21.7% | 20.6% | 18.9% | 26.4% | 25.9% | 11.0% | 31.6% | 34.3% | 35.7% | 42.6% | 33.6% | 12.2% | 38.4% | 42.5% | 34.2% | 46.0% | 36.7% | 47.4% | 44.1% | 60.3% | 47.3% | 45.0% | 32.8% | 29.8% | 44.8% | 35.1% | 25.9% | 30.7% | 30.0% | 33.8% | 23.0% | 40.4% | 36.0% | 24.2% | 26.7% | 37.9% | 38.9% | 21.7% | 20.2% | 30.2% | 27.9% | |
| 32.3% | 30.2% | 36.2% | 38.5% | 40.6% | 37.6% | 41.6% | 43.3% | 40.8% | 37.7% | 44.1% | 18.1% | 47.6% | 51.0% | 40.0% | 50.6% | 47.2% | 53.7% | 52.8% | 74.7% | 55.1% | 52.3% | 38.8% | 36.8% | 55.1% | 42.2% | 30.8% | 38.2% | 36.7% | 37.2% | 26.4% | 49.7% | 43.8% | 28.9% | 34.4% | 45.1% | 51.1% | 30.9% | 26.8% | 38.7% | 37.0% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.